Form 8-K - Current report:
SEC Accession No. 0000950170-24-116853
Filing Date
2024-10-24
Accepted
2024-10-24 07:40:21
Documents
85
Period of Report
2024-10-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prld-20241024.htm   iXBRL 8-K 50503
2 EX-99.1 prld-ex99_1.htm EX-99.1 44977
3 EX-99.2 prld-ex99_2.htm EX-99.2 69531
4 GRAPHIC img268059179_0.jpg GRAPHIC 5700
5 GRAPHIC prld-ex99_2s1.jpg GRAPHIC 449502
6 GRAPHIC prld-ex99_2s2.jpg GRAPHIC 686518
7 GRAPHIC prld-ex99_2s3.jpg GRAPHIC 344538
8 GRAPHIC prld-ex99_2s4.jpg GRAPHIC 353668
9 GRAPHIC prld-ex99_2s5.jpg GRAPHIC 437451
10 GRAPHIC prld-ex99_2s6.jpg GRAPHIC 472086
11 GRAPHIC prld-ex99_2s7.jpg GRAPHIC 266226
12 GRAPHIC prld-ex99_2s8.jpg GRAPHIC 467037
13 GRAPHIC prld-ex99_2s9.jpg GRAPHIC 377639
14 GRAPHIC prld-ex99_2s10.jpg GRAPHIC 404838
15 GRAPHIC prld-ex99_2s11.jpg GRAPHIC 401215
16 GRAPHIC prld-ex99_2s12.jpg GRAPHIC 508724
17 GRAPHIC prld-ex99_2s13.jpg GRAPHIC 421706
18 GRAPHIC prld-ex99_2s14.jpg GRAPHIC 542299
19 GRAPHIC prld-ex99_2s15.jpg GRAPHIC 469345
20 GRAPHIC prld-ex99_2s16.jpg GRAPHIC 457816
21 GRAPHIC prld-ex99_2s17.jpg GRAPHIC 415405
22 GRAPHIC prld-ex99_2s18.jpg GRAPHIC 403213
23 GRAPHIC prld-ex99_2s19.jpg GRAPHIC 446270
24 GRAPHIC prld-ex99_2s20.jpg GRAPHIC 410237
25 GRAPHIC prld-ex99_2s21.jpg GRAPHIC 490408
26 GRAPHIC prld-ex99_2s22.jpg GRAPHIC 410516
27 GRAPHIC prld-ex99_2s23.jpg GRAPHIC 431619
28 GRAPHIC prld-ex99_2s24.jpg GRAPHIC 426924
29 GRAPHIC prld-ex99_2s25.jpg GRAPHIC 498389
30 GRAPHIC prld-ex99_2s26.jpg GRAPHIC 553884
31 GRAPHIC prld-ex99_2s27.jpg GRAPHIC 303112
32 GRAPHIC prld-ex99_2s28.jpg GRAPHIC 411939
33 GRAPHIC prld-ex99_2s29.jpg GRAPHIC 507673
34 GRAPHIC prld-ex99_2s30.jpg GRAPHIC 515376
35 GRAPHIC prld-ex99_2s31.jpg GRAPHIC 447689
36 GRAPHIC prld-ex99_2s32.jpg GRAPHIC 297055
37 GRAPHIC prld-ex99_2s33.jpg GRAPHIC 434779
38 GRAPHIC prld-ex99_2s34.jpg GRAPHIC 399817
39 GRAPHIC prld-ex99_2s35.jpg GRAPHIC 318303
40 GRAPHIC prld-ex99_2s36.jpg GRAPHIC 371540
41 GRAPHIC prld-ex99_2s37.jpg GRAPHIC 312808
42 GRAPHIC prld-ex99_2s38.jpg GRAPHIC 395027
43 GRAPHIC prld-ex99_2s39.jpg GRAPHIC 359843
44 GRAPHIC prld-ex99_2s40.jpg GRAPHIC 357608
45 GRAPHIC prld-ex99_2s41.jpg GRAPHIC 384308
46 GRAPHIC prld-ex99_2s42.jpg GRAPHIC 387942
47 GRAPHIC prld-ex99_2s43.jpg GRAPHIC 403189
48 GRAPHIC prld-ex99_2s44.jpg GRAPHIC 412732
49 GRAPHIC prld-ex99_2s45.jpg GRAPHIC 440345
50 GRAPHIC prld-ex99_2s46.jpg GRAPHIC 487323
51 GRAPHIC prld-ex99_2s47.jpg GRAPHIC 463306
52 GRAPHIC prld-ex99_2s48.jpg GRAPHIC 459504
53 GRAPHIC prld-ex99_2s49.jpg GRAPHIC 461217
54 GRAPHIC prld-ex99_2s50.jpg GRAPHIC 274895
55 GRAPHIC prld-ex99_2s51.jpg GRAPHIC 384796
56 GRAPHIC prld-ex99_2s52.jpg GRAPHIC 379063
57 GRAPHIC prld-ex99_2s53.jpg GRAPHIC 393454
58 GRAPHIC prld-ex99_2s54.jpg GRAPHIC 287574
59 GRAPHIC prld-ex99_2s55.jpg GRAPHIC 369305
60 GRAPHIC prld-ex99_2s56.jpg GRAPHIC 366747
61 GRAPHIC prld-ex99_2s57.jpg GRAPHIC 417615
62 GRAPHIC prld-ex99_2s58.jpg GRAPHIC 361259
63 GRAPHIC prld-ex99_2s59.jpg GRAPHIC 329404
64 GRAPHIC prld-ex99_2s60.jpg GRAPHIC 380109
65 GRAPHIC prld-ex99_2s61.jpg GRAPHIC 481792
66 GRAPHIC prld-ex99_2s62.jpg GRAPHIC 515463
67 GRAPHIC prld-ex99_2s63.jpg GRAPHIC 598816
68 GRAPHIC prld-ex99_2s64.jpg GRAPHIC 566150
69 GRAPHIC prld-ex99_2s65.jpg GRAPHIC 368926
70 GRAPHIC prld-ex99_2s66.jpg GRAPHIC 325777
71 GRAPHIC prld-ex99_2s67.jpg GRAPHIC 378328
72 GRAPHIC prld-ex99_2s68.jpg GRAPHIC 392303
73 GRAPHIC prld-ex99_2s69.jpg GRAPHIC 345895
74 GRAPHIC prld-ex99_2s70.jpg GRAPHIC 461801
75 GRAPHIC prld-ex99_2s71.jpg GRAPHIC 318205
  Complete submission text file 0000950170-24-116853.txt   41082244

Data Files

Seq Description Document Type Size
76 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT prld-20241024.xsd EX-101.SCH 50257
87 EXTRACTED XBRL INSTANCE DOCUMENT prld-20241024_htm.xml XML 4721
Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

EIN.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39527 | Film No.: 241390734
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)